TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23020760

Group type: EXPERIMENTAL
Intervention: 0.5 L beetroot (BR) juice
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.5 L placebo (PLA) drink with blackcurrant juice
Number of subjects: 10
Study: 21698578

Group type: EXPERIMENTAL
Intervention: Short rotators intact
Number of subjects: 68

Group type: COMPARATOR
Intervention: Short rotators released
Number of subjects: 68
Study: 18082668

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 158

Group type: COMPARATOR
Intervention: Ibuprofen 800 mg
Number of subjects: 158
Study: 16293396

Group type: EXPERIMENTAL
Intervention: 6-week combined treatment approach using vocal function exercises (VFEs) and vocal hygiene (VH) education
Number of subjects: 20

Group type: COMPARATOR
Intervention: No-treatment control
Number of subjects: 20
Study: 12898761

Group type: EXPERIMENTAL
Intervention: Intra-articular injection with 1.0 ml of 2% chitosan
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group with 12.5 mg of prednisolone
Number of subjects: 30
Study: 11303537

Group type: EXPERIMENTAL
Intervention: Inhalation of 3 ml 1% l-menthol solution
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo inhalation of 3 ml 0.05% l-menthol
Number of subjects: 64
Study: 9302365

Group type: EXPERIMENTAL
Intervention: Oral prednisone
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Retrobulbar irradiation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (non-responders)
Number of subjects: 43
Study: 8362837

Group type: EXPERIMENTAL
Intervention: Coloscreen Self-Test
Number of subjects: 283

Group type: COMPARATOR
Intervention: Guaiac cards
Number of subjects: 283

Group type: EXPERIMENTAL
Intervention: Coloscreen Self-Test (VA clinic)
Number of subjects: 283

Group type: COMPARATOR
Intervention: Guaiac cards (VA clinic)
Number of subjects: 283
Study: 2426514

Group type: EXPERIMENTAL
Intervention: Iloprost 0.5 ng/kg X min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Iloprost 1.0 ng/kg X min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Iloprost 2.0 ng/kg X min
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Iloprost 3.0 ng/kg X min
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 29658504

Group type: EXPERIMENTAL
Intervention: Nooclerin (deanoli aceglumas)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 28513852

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (1200 mg orally before thrombolytic therapy)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control group (standard protocol for treatment of MI)
Number of subjects: 98
Study: 26701110

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 899

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 899

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 899

Group type: COMPARATOR
Intervention: Sitagliptin 100 mg
Number of subjects: 899
Study: 23394895

Group type: EXPERIMENTAL
Intervention: Algisyl‐LVR™+CABG
Number of subjects: 3
Study: 21410296

Group type: EXPERIMENTAL
Intervention: HX575
Number of subjects: 268

Group type: COMPARATOR
Intervention: Epogen®
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: HX575-TT
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Erypo®/Eprex®
Number of subjects: 268
Study: 18205579

Group type: EXPERIMENTAL
Intervention: Low-ankle-pressure graduated-compression tights (GCTs)
Number of subjects: 47
Study: 16341712

Group type: EXPERIMENTAL
Intervention: Flexion-distraction (FD)
Number of subjects: 235

Group type: COMPARATOR
Intervention: Active trunk exercise protocol (ATEP)
Number of subjects: 235
Study: 12732372

Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Applied relaxation (AR)
Number of subjects: 45
Study: 10936631

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Nortriptyline (NT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Standardized treatment (IPT or NT)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 181
Study: 9065248

Group type: EXPERIMENTAL
Intervention: Sufentanil-propofol
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fentanyl-propofol
Number of subjects: 18
Study: 2052740

Group type: EXPERIMENTAL
Intervention: Controlled-release hydrogel polymer prostaglandin E2 pessary (0.6 mg PGE2 per hour)
Number of subjects: 0
Study: 6192652

Group type: EXPERIMENTAL
Intervention: H1 receptor blockade alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: H1 receptor blockade in combination with H2 receptor blockade
Number of subjects: 20

Group type: COMPARATOR
Intervention: H2 receptor blockade alone
Number of subjects: 20
Study: 31906882

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting disease-specific survival (DSS) rates
Number of subjects: 5764
Study: 31283830

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Health Enhancement Program (HEP)
Number of subjects: 25
Study: 27977472

Group type: EXPERIMENTAL
Intervention: Nitrendipine and hydrochlorothiazide
Number of subjects: 793

Group type: COMPARATOR
Intervention: Nitrendipine and metoprolol
Number of subjects: 793
Study: 25847112

Group type: EXPERIMENTAL
Intervention: Use of antidepressants (mainly selective serotonin reuptake inhibitors)
Number of subjects: 138704

Group type: EXPERIMENTAL
Intervention: Thrombocytopenia
Number of subjects: 138704
Study: 23551394

Group type: EXPERIMENTAL
Intervention: Community health workers training
Number of subjects: 57
Study: 20651608

Group type: EXPERIMENTAL
Intervention: Experimental group (E) - 90 maximal isokinetic eccentric-concentric knee extensor contractions on each of 3 consecutive days followed by 1-day rest, then on 4 more consecutive days.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Experimental group (E)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (C) - did not train but performed all exercise tests; CK and LDH measured at 3 time points only.
Number of subjects: 17
Study: 19415289

Group type: EXPERIMENTAL
Intervention: Multidetector CT after oral administration of polyethylene glycol solution (n = 21)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Multidetector CT after administration of methylcellulose via nasojejunal tube (n = 13)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Endoscopy
Number of subjects: 34
Study: 16893664

Group type: EXPERIMENTAL
Intervention: Aneurysm patients without previous related hospitalisation
Number of subjects: 4816

Group type: EXPERIMENTAL
Intervention: Aneurysm patients with previous hospitalisation for pulmonary causes
Number of subjects: 4816
Study: 15145874

Group type: EXPERIMENTAL
Intervention: AAIR pacing (n = 54)
Number of subjects: 177

Group type: COMPARATOR
Intervention: DDDR with short rate adaptive AV delay (DDDR-s) (n = 60)
Number of subjects: 177

Group type: COMPARATOR
Intervention: DDDR with fixed long AV delay (DDDR-l) (n = 63)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Brady-tachy syndrome
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Thromboembolic event before pacemaker implantation
Number of subjects: 177
Study: 11162695

Group type: EXPERIMENTAL
Intervention: Prone position CT myelography
Number of subjects: 21

Group type: COMPARATOR
Intervention: Supine position CT myelography
Number of subjects: 21
Study: 9782018

Group type: EXPERIMENTAL
Intervention: Rifampicin-bonded Dacron grafts (n=123)
Number of subjects: 257

Group type: COMPARATOR
Intervention: Control group (unbonded Dacron grafts, n=134)
Number of subjects: 257
Study: 8872373

Group type: EXPERIMENTAL
Intervention: Optisol
Number of subjects: 20

Group type: COMPARATOR
Intervention: H-Sol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both Optisol and H-Sol
Number of subjects: 20
Study: 1700077

Group type: EXPERIMENTAL
Intervention: Cisplatin plus vinblastine plus bleomycin (PVB) chemotherapy
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cisplatin plus etoposide (VP-16)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Cisplatin plus VP-16 plus bleomycin (PVP16B)
Number of subjects: 47

Group type: COMPARATOR
Intervention: PVB
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Salvage chemotherapy
Number of subjects: 47
Study: 7377916

Group type: EXPERIMENTAL
Intervention: Naloxone (20 mg, intravenous)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30783957

Group type: EXPERIMENTAL
Intervention: Baclofen 5% cream
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 31708152

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole (20 mg trimethoprim and 100 mg sulfamethoxazole orally for infants <6 months or <5 kg; 40 mg trimethoprim and 200 mg sulfamethoxazole orally for infants >6 months or >5 kg)
Number of subjects: 1219

Group type: COMPARATOR
Intervention: No co-trimoxazole
Number of subjects: 1219
Study: 28917377

Group type: EXPERIMENTAL
Intervention: Beeswax, olive oil and Alkanna tinctoria mixture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group routine dressing
Number of subjects: 64
Study: 27370878

Group type: EXPERIMENTAL
Intervention: Pirfenidone (801 mg/day titrated to 2403 mg/day over 16 weeks)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Pirfenidone with 2-week titration
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Pirfenidone with 4-week titration
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Pirfenidone with concomitant Mycophenolate mofetil (MMF)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Exploratory disease outcomes
Number of subjects: 63
Study: 24634424

Group type: EXPERIMENTAL
Intervention: Tactile stimulation (rubbing the skin adjacent to the injection site or applying pressure)
Number of subjects: 121

Group type: COMPARATOR
Intervention: No tactile stimulation (control)
Number of subjects: 121
Study: 23241431

Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (tVNS)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sham transcutaneous vagus nerve stimulation (sham tVNS)
Number of subjects: 120
Study: 20669666

Group type: EXPERIMENTAL
Intervention: Intracoronary administering of 10 mL (0.5 mg) tirofiban and 400 mg XST, followed by 36 h continuous intravenous dripping of tirofiban 10 mL/h and 400 mg XST in 250 mL of saline for dripping.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Intracoronary administering of 10 mL (0.5 mg) tirofiban, followed by 36 h continuous intravenous dripping of tirofiban 10 mL/h without XST.
Number of subjects: 39
Study: 17442201

Group type: EXPERIMENTAL
Intervention: Janus stent (n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tecnic Carbostent (bare metal stent, n = 100)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Tecnic Carbostent
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Janus stent
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study: 16253721

Group type: EXPERIMENTAL
Intervention: Nephrologist A's urinalysis (UA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clinical laboratory UA report reviewed by Nephrologist B
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clinical laboratory UA report reviewed by Nephrologist A
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist B reviewing UA reports from Nephrologist A
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's review of urine sediment
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's report of renal tubular epithelial (RTE) cells
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's report of granular casts
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's report of hyaline casts
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's report of RTE casts
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Nephrologist A's report of dysmorphic red blood cells
Number of subjects: 26

Group type: COMPARATOR
Intervention: Clinical laboratory report of squamous cells
Number of subjects: 26
Study: 12164876

Group type: EXPERIMENTAL
Intervention: ET‐A receptor antagonist BQ‐123 (40 nmol/min)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: ET‐B receptor antagonist BQ‐788 (1 and 50 nmol/min)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: BQ‐123 plus BQ‐788 (50 nmol/min)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: ET (5 pmol/min)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Adenosine and norepinephrine
Number of subjects: 2
Study: 9205027

Group type: EXPERIMENTAL
Intervention: Concentric left ventricular hypertrophy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Other geometric patterns
Number of subjects: 0
Study: 8352038

Group type: EXPERIMENTAL
Intervention: Silver acetate mouth spray, used every 2 hours for 3 weeks
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo spray, used every 2 hours for 3 weeks
Number of subjects: 42
Study: 3676054

Group type: EXPERIMENTAL
Intervention: HFJV using a frequency of 100 b.p.m. via a proximal injector cannula
Number of subjects: 14

Group type: COMPARATOR
Intervention: HFJV using three frequencies (100, 300 and 600 b.p.m.) via a 1.8‐mm i.d. proximal injector cannula (proximal injection)
Number of subjects: 14
Study: 30173835

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with a continuous beam 660-nm, 75-mW laser applied for 15 seconds at 8 points for a total treatment time of 2 minutes.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham treatment (control group).
Number of subjects: 20
Study: 26762525

Group type: EXPERIMENTAL
Intervention: Cangrelor
Number of subjects: 11145

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 11145
Study: 25044172

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with language training
Number of subjects: 290

Group type: COMPARATOR
Intervention: Speech and language therapy (SLT) alone
Number of subjects: 290
Study: 22966124

Group type: EXPERIMENTAL
Intervention: artesunate-primaquine
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: primaquine
Number of subjects: 433
Study: 20337203

Group type: EXPERIMENTAL
Intervention: Intravaginal electrical stimulation (IVES)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 18216565

Group type: EXPERIMENTAL
Intervention: CRT lens wear
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: CRTH lens wear
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control eyes
Number of subjects: 20
Study: 15811140

Group type: EXPERIMENTAL
Intervention: DZX 100 mg three times daily for 6 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DZX 50 mg three times daily for 6 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DZX 75 mg three times daily for 6 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DZX 50 mg in non-obese men
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: DZX 100 mg in non-obese men
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 11989838

Group type: EXPERIMENTAL
Intervention: Butyrate (100 mM) enema for 8 weeks
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo enema for 8 weeks
Number of subjects: 11
Study: 10521743

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Labetalol
Number of subjects: 6
Study: 7567409

Group type: EXPERIMENTAL
Intervention: Accurate feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inaccurate feedback (overestimate)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inaccurate feedback (underestimate)
Number of subjects: 0
Study: 2065699

Group type: EXPERIMENTAL
Intervention: Liv.52
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6853873

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment program (4 weeks of coping-skills training using behavioral rehearsal and self-instruction training)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Non-treatment control group
Number of subjects: 41
Study: 31347247

Group type: EXPERIMENTAL
Intervention: TEA + DBT + ESO (group B)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sham-TEA + DBT + ESO (group C)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Esomeprazole (ESO, 20 mg bid) (group A)
Number of subjects: 21
Study: 28619486

Group type: EXPERIMENTAL
Intervention: Extended-depth-of-focus prototypes (EDOF)
Number of subjects: 43
Study: 25644375

Group type: EXPERIMENTAL
Intervention: Nurse-led discharge planning program for childhood asthma management
Number of subjects: 120
Study: 24406025

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.25mg BID for 2 weeks, then 0.5mg BID for 10 weeks
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Discontinuation of ondansetron
Number of subjects: 21
Study: 23131371

Group type: EXPERIMENTAL
Intervention: Monochord (MC) sounds
Number of subjects: 40

Group type: COMPARATOR
Intervention: Progressive muscle relaxation (PMR)
Number of subjects: 40
Study: 20574649

Group type: EXPERIMENTAL
Intervention: ETN 25 mg twice a week and MTX 6‐8 mg/week (E + M group)
Number of subjects: 151

Group type: COMPARATOR
Intervention: ETN alone (E group)
Number of subjects: 151
Study: 17310130

Group type: EXPERIMENTAL
Intervention: Pilocarpine 20 mg/day orally for 7 days
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 15883634

Group type: EXPERIMENTAL
Intervention: Fok1 polymorphism of the VDR
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fok1 polymorphism of the VDR with Ca intake >800 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fok1 polymorphism of the VDR with Ca intake <= 800 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Fok1 genotype (ff)
Number of subjects: 99
Study: 12379164

Group type: EXPERIMENTAL
Intervention: Reduction in systolic blood pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased pulse pressure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction in pulse pressure
Number of subjects: 0
Study: 9665234

Group type: EXPERIMENTAL
Intervention: First RNMI in the first year after index infarction
Number of subjects: 3867

Group type: EXPERIMENTAL
Intervention: First RNMI in the second year after index infarction
Number of subjects: 3867

Group type: EXPERIMENTAL
Intervention: First RNMI in the third year after index infarction
Number of subjects: 3867

Group type: EXPERIMENTAL
Intervention: First RNMI in the fourth year after index infarction
Number of subjects: 3867

Group type: COMPARATOR
Intervention: Comparison of all groups
Number of subjects: 3867
Study: 9764869

Group type: EXPERIMENTAL
Intervention: Danazol/exercise regimen
Number of subjects: 39
Study: 2750862

Group type: EXPERIMENTAL
Intervention: Videotaped instruction (25-minute videotape demonstrating the Milani-Comparetti Motor Development Screening Test)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Live instruction (information provided by an instructor)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Both groups rated the learning experience as good.
Number of subjects: 23
Study: 681534

Group type: EXPERIMENTAL
Intervention: Therapeutic suggestion (feedback indicating they could remain calm and relaxed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No therapeutic suggestion (no feedback given)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exposure to stressful situation (threat)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No exposure to stressful situation (no threat)
Number of subjects: 0
Study: 31821750

Group type: EXPERIMENTAL
Intervention: Itacitinib (10-300 mg, 500 mg, 1000 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31196032

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg PO once daily for 6 months during SRT
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: SRT with enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28513555

Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (400 IU/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-intervention (control group)
Number of subjects: 0
Study: 25719991

Group type: EXPERIMENTAL
Intervention: Ranibizumab plus prompt or deferred focal/grid laser treatment
Number of subjects: 582

Group type: COMPARATOR
Intervention: Sham injection plus focal/grid laser treatment
Number of subjects: 582
Study: 22899589

Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZES)
Number of subjects: 2645

Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 2645

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 2645
Study: 20213132

Group type: EXPERIMENTAL
Intervention: Colpexin Sphere with pelvic floor muscle exercise
Number of subjects: 50

Group type: COMPARATOR
Intervention: Pelvic floor exercise only
Number of subjects: 50
Study: 19088159

Group type: COMPARATOR
Intervention: Testosterone (Te) / Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Testosterone (Te) / Dutasteride
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Testosterone (Te) / Anastrozole
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Testosterone (Te)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Testosterone (Te) and Estradiol (E(2))
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Dihydrotestosterone (DHT)
Number of subjects: 42
Study: 16438751

Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg intravenously 3 min before induction of anaesthesia
Number of subjects: 68

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 68
Study: 12780746

Group type: EXPERIMENTAL
Intervention: Soy protein containing isoflavones
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 10701612

Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Sustained virologic responders
Number of subjects: 59

Group type: COMPARATOR
Intervention: Non-responders
Number of subjects: 59
Study: 9354348

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 800 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 8222508

Group type: EXPERIMENTAL
Intervention: Angiotensin II (low dose: 1 ng min-1kg-1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Angiotensin II (high dose: 5 ng min-1kg-1)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 2419383

Group type: EXPERIMENTAL
Intervention: Partially purified cat- or dog-dander extracts
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39